Literature DB >> 8823851

Risk of infection with hepatitis A, B or C, cytomegalovirus, varicella or measles among child care providers.

L A Jackson1, L K Stewart, S L Solomon, J Boase, E R Alexander, J L Heath, G K McQuillan, P J Coleman, J A Stewart, C N Shapiro.   

Abstract

BACKGROUND: Employment as a child care provider has been suggested as an indication for hepatitis A virus (HAV) immunization; however, whether this occupational group is at increased risk of HAV infection is not well-defined.
METHODS: We obtained sera samples for testing for antibodies to hepatitis A, B and C, cytomegalovirus, varicella and measles from a sample of child care providers in King County, WA, and administered a questionnaire to assess employment characteristics and other potential risk factors for infection. We also compared the anti-HAV seroprevalence among providers with that of subjects in the Third National Health and Nutrition Survey, representative of the US general population.
RESULTS: Thirteen percent (48 of 360) of providers were anti-HAV-positive (46% (22 of 47) of foreign born vs. 8% (26 of 313) of US-born (P < 0.001)). In multivariate analysis anti-HAV seropositivity was associated with foreign birth, age, income and Hispanic ethnicity but was not associated with characteristics of employment. Seroprevalence among US-born providers tended to be lower than that among Third National Health and Nutrition Survey subjects of similar age, sex, race and income. Sixty-two percent of providers were seropositive to cytomegalovirus, which was associated with nonwhite race, changing diapers > or = 3 days/week while at work and having a child in the household. Antibody prevalence was 1.4% to hepatitis B core antigen, 0.6% to hepatitis C, 94% to measles and 98% to varicella.
CONCLUSIONS: The anti-HAV prevalence among US-born providers was low, and seropositivity was not associated with employment characteristics, indicating that occupational exposure to HAV is uncommon under non-outbreak circumstances.

Entities:  

Mesh:

Year:  1996        PMID: 8823851     DOI: 10.1097/00006454-199607000-00005

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  7 in total

1.  Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study.

Authors:  G Vandersmissen; G Moens; R Vranckx; A de Schryver; P Jacques
Journal:  Occup Environ Med       Date:  2000-09       Impact factor: 4.402

Review 2.  Active immunization in the United States: developments over the past decade.

Authors:  P H Dennehy
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

3.  Cytomegalovirus as an occupational risk in daycare educators.

Authors:  Serene A Joseph; Claire Béliveau; Cristin J Muecke; Elham Rahme; Julio C Soto; Gordon Flowerdew; Lynn Johnston; Donald Langille; Theresa W Gyorkos
Journal:  Paediatr Child Health       Date:  2006-09       Impact factor: 2.253

4.  Socioeconomic and psychosocial gradients in cardiovascular pathogen burden and immune response: the multi-ethnic study of atherosclerosis.

Authors:  Allison E Aiello; Ana Diez-Roux; Anne-Michelle Noone; Nalini Ranjit; Mary Cushman; Michael Y Tsai; Moyses Szklo
Journal:  Brain Behav Immun       Date:  2008-12-25       Impact factor: 7.217

5.  Are female daycare workers at greater risk of cytomegalovirus infection? A secondary data analysis of CMV seroprevalence between 2010 and 2013 in Hamburg, Germany.

Authors:  Johanna Stranzinger; Agnessa Kozak; Benjamin Schilgen; Diana Paris; Thomas Nießen; Lutz Schmidt; Andreas Wille; Norbert L Wagner; Albert Nienhaus
Journal:  GMS Hyg Infect Control       Date:  2016-04-21

Review 6.  Infection control challenges in child-care centers.

Authors:  R B Churchill; L K Pickering
Journal:  Infect Dis Clin North Am       Date:  1997-06       Impact factor: 5.982

7.  Risk of Staphylococcus aureus carriage in childcare employees.

Authors:  E D Moritz; T C Smith
Journal:  Epidemiol Infect       Date:  2012-11-23       Impact factor: 4.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.